GlaxoSmithKline Pharmaceuticals Limited announced appointment of Mr. Juby Chandy as Chief Financial Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,430 INR | -1.78% | +6.06% | +28.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.09% | 4.96B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- GLAXO Stock
- News GlaxoSmithKline Pharmaceuticals Limited
- GlaxoSmithKline Pharmaceuticals Limited Announces Appointment of Juby Chandy as Chief Financial Officer